Plexus Announces Fiscal First Quarter 2017 Financial

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
334
Plexus Announces Fiscal First Quarter 2017 Financial Results
  • Fiscal first quarter 2017 revenue of $635 million
  • GAAP diluted EPS of $0.82
  • Initiates fiscal second quarter 2017 revenue guidance of $620 to $650 million with GAAP diluted EPS of $0.71 to $0.79.

NEENAH, Wis., Jan. 18, 2017 (GLOBE NEWSWIRE) -- Plexus (NASDAQ: PLXS ) today announced financial results for its fiscal first quarter ended December 31, 2016, and guidance for its fiscal second quarter ending April 1, 2017.

    Three Months Ended
    Dec 31, 2016   Dec 31, 2016   Apr 1, 2017
    Q1F17 Results   Q1F17 Guidance   Q2F17 Guidance
Summary GAAP Items          
Revenue (in millions)   $ 635       $620 to $650   $620 to $650
Operating margin   5.3 %     4.9% to 5.2%   4.9% to 5.2%
Diluted EPS (1)   $ 0.82       $0.74 to $0.82   $0.71 to $0.79
                 
Summary Non-GAAP Items (2)              
Return on invested capital (ROIC)   17.3 %          
Economic Return   6.8 %          
(1 )  Includes stock-based compensation expense of $0.10 for Q1F17 results and $0.11 for Q2F17 guidance.
(2 )  Refer to Non-GAAP Supplemental Information in Tables 1 and 2 for non-GAAP financial measures discussed in this release, such as ROIC and Economic Return, and a reconciliation of these measures to GAAP.
                 

Fiscal First Quarter 2017 Information

  • Won 51 Manufacturing Solutions programs during the quarter representing approximately $217 million in annualized revenue when fully ramped into production
  • Trailing four quarter Manufacturing Solutions wins total approximately $785 million in annualized revenue
  • Purchased $7.1 million of our shares at an average price of $48.79 per share

Todd Kelsey, President and CEO, commented, “Late in the fiscal first quarter we fulfilled a broad-based pull-in of demand from customers within our Communications market sector that offset weaker than anticipated revenue from the Defense/Security/Aerospace market sector.  Consequently, fiscal first quarter revenue of $635 million was at the midpoint of our guidance range.  Strong operating performance enabled us to achieve GAAP diluted EPS of $0.82, at the top of our guidance range.” 

Mr. Kelsey continued, “Looking forward to our fiscal second quarter, we currently anticipate revenue in the range of $620 to $650 million.  The midpoint of this guidance suggests revenue will be sequentially flat.  Underlying revenue growth is expected to be offset by end-market weakness within the Communications market sector and an additional delay to the previously disclosed orders from a large Industrial/Commercial customer.  As a result of our continued strong operating performance, we are guiding GAAP diluted EPS in the range of $0.71 to $0.79.  Overall, our wins performance continues to accelerate with new program ramps progressing as anticipated, supporting our goal of achieving a $3 billion annual revenue run rate as we exit the fiscal year.”

Patrick Jermain, Senior Vice President and CFO, commented, “During the fiscal first quarter we generated $73 million in free cash flow, a result well above our projections.  Results from working capital initiatives drove fiscal first quarter cash cycle to 66 days, which was favorable to our expectations.”  Mr. Jermain continued, “Our sustained operating performance delivered fiscal first quarter GAAP operating margin of 5.3%.  We are pleased to guide GAAP operating margins in the range of 4.9% to 5.2% for the fiscal second quarter, even with absorbing seasonal compensation cost increases and the reset of US payroll taxes.”

Quarterly Comparison Three Months Ended
  Dec 31, 2016   Oct 1, 2016   Jan 2, 2016
(in thousands, except EPS) Q1F17   Q4F16   Q1F16
Revenue $ 635,019     $ 653,064     $ 616,664  
Gross profit $ 64,356     $ 61,530     $ 50,059  
Operating profit $ 33,903     $ 23,651     $ 21,524  
Net income $ 28,179     $ 19,093     $ 14,448  
Diluted EPS $ 0.82     $ 0.56     $ 0.42  
Adjusted net income* $ 28,179     $ 28,261     $ 15,955  
Adjusted diluted EPS* $ 0.82     $ 0.82     $ 0.47  
           
Gross margin   10.1 %     9.4 %     8.1 %
Adjusted gross margin**   10.1 %     9.9 %     8.1 %
Operating margin   5.3 %     3.6 %     3.5 %
Adjusted operating margin*   5.3 %     5.1 %     3.7 %
                       
ROIC*   17.3 %     13.8 %     10.8 %
Economic Return*   6.8 %     2.8 %     -0.2 %
           
*Refer to Non-GAAP Supplemental Information Tables 1 and 2 for a reconciliation to GAAP measures.
**Q4F16 adjusted gross margin excludes $2.9 million of primarily inventory losses sustained from a typhoon that impacted the Company's manufacturing facilities in Xiamen, China that were recorded in cost of sales.
 

Non-GAAP Financial Measures Plexus provides non-GAAP supplemental information, such as ROIC, Economic Return, and free cash flow, because such measures are used for internal management goals and decision making, and because they provide management and investors additional insight into financial performance.  In addition, management uses these and other non-GAAP measures, such as adjusted net income, adjusted gross margin and adjusted operating margin, to provide a better understanding of core performance for purposes of period-to-period comparisons.  Plexus believes that these measures are also useful to investors because they provide further insight by eliminating the effect of items that are not reflective of continuing operations.  For a full reconciliation of non-GAAP measures to comparable GAAP measures, please refer to Non-GAAP Supplemental Information and the attached Non-GAAP Supplemental Information Tables.

Market Sector and Business Segment Revenue Plexus reports revenue based on the market sector breakout set forth in the table below, which reflects the Company’s global market sector focused business development strategy.  The Company measures operational performance and allocates resources on a geographic segment basis.  Top 10 customers comprised 60% of revenue during the quarter, up one percentage point from the fiscal fourth quarter of 2016.

Market Sectors ($ in millions) Three Months Ended
  Dec 31, 2016 Q1F17   Oct 1, 2016 Q4F16   Jan 2, 2016 Q1F16
Healthcare/Life Sciences $ 211     33 %     $ 192     29 %     $ 191     31 %
Industrial/Commercial 206   32 %   231   35 %   173   28 %
Communications 131   21 %   128   20 %   157   25 %
Defense/Security/Aerospace 87   14 %   102   16 %   96   16 %
Total Revenue $ 635       $ 653       $ 617    
                             
Business Segments ($ in millions) Three Months Ended
  Dec 31, 2016 Q1F17   Oct 1, 2016 Q4F16   Jan 2, 2016 Q1F16
Americas $ 315     $ 334     $ 305  
Asia-Pacific 310     299     300  
Europe, Middle East, and Africa 39     44     42  
Elimination of inter-segment sales (29 )   (24 )   (30 )
Total Revenue $ 635     $ 653     $ 617  
                       

Non-GAAP Supplemental Information

ROIC and Economic Return ROIC for the fiscal first quarter of 2017 was 17.3%.  The Company defines ROIC as tax-effected annualized adjusted operating profit divided by average invested capital over a two-quarter period for the first quarter.  Invested capital is defined as equity plus debt, less cash and cash equivalents. The Company’s weighted average cost of capital for fiscal 2017 is 10.5%.  ROIC for the quarter less the Company’s weighted average cost of capital resulted in an Economic Return of 6.8%.

Cash Conversion Cycle Three Months Ended
  Dec 31, 2016 Q1F17   Oct 1, 2016 Q4F16   Jan 2, 2016 Q1F16
Days in Accounts Receivable 49     58     53  
Days in Inventory 90     87     88  
Days in Accounts Payable (60 )   (61 )   (59 )
Days in Cash Deposits (13 )   (13 )   (11 )
Annualized Cash Cycle* 66     71     71  
*We calculate cash cycle as the sum of days in accounts receivable and days in inventory, less days in accounts payable and days in cash deposits.
 

Free Cash Flow Calculation The Company defines free cash flow as cash flows provided by operations less capital expenditures.  For the three months ended December 31, 2016, cash flows provided by operations was $79.5 million, less capital expenditures of $7.0 million, resulting in free cash flow of $72.5 million.

Conference Call and Webcast Information

What: Plexus Fiscal Q1 2017 Earnings Conference Call and Webcast
When: Thursday, January 19, 2017 at 8:30 a.m. Eastern Time
Where:   Participants are encouraged to join the live webcast at the investor relations section of the Plexus website, www.plexus.com  or directly at:  http://edge.media-server.com/m/p/ktx495yw/lan/en
   
  Conference call at +1.800.708.4540 with passcode: 43948707
   
Replay: The webcast will be archived on the Plexus website and available via telephone replay at +1.888.843.7419 or +1.630.652.3042 with passcode: 43948707
   

About Plexus – The Product Realization Company  Plexus ( www.plexus.com ) delivers optimized Product Realization solutions through a unique Product Realization Value Stream service model.  This customer-focused services model seamlessly integrates innovative product conceptualization, design, commercialization, manufacturing, fulfillment and sustaining services to deliver comprehensive end-to-end solutions for customers in the America, European and Asia-Pacific regions.

Plexus is the industry leader in servicing mid-to-low volume, higher complexity customer programs characterized by unique flexibility, technology, quality and regulatory requirements.  Award-winning customer service is provided to over 140 branded product companies in the Healthcare/Life Sciences, Industrial/Commercial, Communications and Defense/Security/Aerospace market sectors.

Safe Harbor and Fair Disclosure Statement The statements contained in this press release that are guidance or which are not historical facts (such as statements in the future tense and statements including believe, expect, intend, plan, anticipate, goal, target and similar terms and concepts), including all discussions of periods which are not yet completed, are forward-looking statements that involve risks and uncertainties. These risks and uncertainties include, but are not limited to: the risk of customer delays, changes, cancellations or forecast inaccuracies in both ongoing and new programs; the lack of visibility of future orders, particularly in view of changing economic conditions; the economic performance of the industries, sectors and customers we serve; the effects of the volume of revenue from certain sectors or programs on our margins in particular periods; our ability to secure new customers, maintain our current customer base and deliver product on a timely basis; the particular risks relative to new or recent customers, programs or services, which risks include customer and other delays, start-up costs, potential inability to execute, the establishment of appropriate terms of agreements, and the lack of a track record of order volume and timing; the risks of concentration of work for certain customers; the effect of start-up costs of new programs and facilities; possible unexpected costs and operating disruption in transitioning programs, including as a result of a facility closure; the risk that new program wins and/or customer demand may not result in the expected revenue or profitability; the fact that customer orders may not lead to long-term relationships; our ability to manage successfully and execute a complex business model characterized by high product mix, low volumes and demanding quality, regulatory, and other requirements; the ability to realize anticipated savings from restructuring or similar actions, as well as the adequacy of related charges as compared to actual expenses; increasing regulatory and compliance requirements; the potential effects of regional results on our taxes and ability to use deferred tax assets and net operating losses; risks related to information technology systems and data security; the effects of shortages and delays in obtaining components as a result of economic cycles or natural disasters; the risks associated with excess and obsolete inventory, including the risk that inventory purchased on behalf of our customers may not be consumed or otherwise paid for by the customer, resulting in an inventory write-off; the weakness of areas of the global economy; the effect of changes in the pricing and margins of products; raw materials and component cost fluctuations; the potential effect of fluctuations in the value of the currencies in which we transact business; potential economic weakness and other effects resulting from the June 2016 vote of the United Kingdom to exit the European Union and the change in the U.S. presidential administration; the potential effect of other world or local events or other events outside our control (such as changes in energy prices, terrorism and weather events); the impact of increased competition; changes in financial accounting standards; and other risks detailed in our Securities and Exchange Commission filings (particularly in "Risk Factors" in our fiscal 2016 Form 10-K).

PLEXUS
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
(unaudited)
   
  Three Months Ended
  Dec 31,   Jan 2,
  2016     2016  
Net sales $ 635,019       $ 616,664  
Cost of sales 570,663     566,605  
Gross profit 64,356     50,059  
Selling and administrative expenses 30,453     27,028  
Restructuring and other charges —     1,507  
Operating income 33,903     21,524  
Other income (expense):      
Interest expense (3,274 )   (3,534 )
Interest income 1,071     932  
Miscellaneous (674 )   (1,620 )
Income before income taxes 31,026     17,302  
Income tax expense 2,847     2,854  
Net income $ 28,179     $ 14,448  
Earnings per share:      
Basic $ 0.84     $ 0.43  
Diluted $ 0.82     $ 0.42  
Weighted average shares outstanding:      
Basic 33,534     33,396  
Diluted 34,544     34,062  
           
PLEXUS
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except per share data)
(unaudited)
       
  Dec 31,   Oct 1,
  2016   2016
ASSETS      
Current assets:      
Cash and cash equivalents $ 496,505       $ 432,964  
Restricted cash 1,342     —  
Accounts receivable 343,661     416,888  
Inventories 564,813     564,131  
Prepaid expenses and other 24,066     19,364  
Total current assets 1,430,387     1,433,347  
Property, plant and equipment, net 284,968     291,225  
Deferred income taxes 4,709     4,834  
Other 36,115     36,413  
Total non-current assets 325,792     332,472  
   Total assets $ 1,756,179     $ 1,765,819  
       
LIABILITIES AND SHAREHOLDERS’ EQUITY      
Current liabilities:      
Current portion of long-term debt and capital lease obligations $ 78,879     $ 78,507  
Accounts payable 375,601     397,200  
Customer deposits 83,491     84,637  
Accrued salaries and wages 40,666     41,806  
Other accrued liabilities 50,256     48,286  
Total current liabilities 628,893     650,436  
Long-term debt and capital lease obligations, net of current portion 184,136     184,002  
Other liabilities 15,608     14,584  
Total non-current liabilities 199,744     198,586  
   Total liabilities 828,637     849,022  
Shareholders’ equity:      
Common stock, $.01 par value, 200,000 shares authorized,      
51,516 and 51,272 shares issued, respectively,      
and 33,556 and 33,457 shares outstanding, respectively 515     513  
Additional paid-in-capital 537,034     530,647  
Common stock held in treasury, at cost, 17,960 and 17,815, respectively (547,029 )   (539,968 )
Retained earnings 965,323     937,144  
Accumulated other comprehensive loss (28,301 )   (11,539 )
Total shareholders’ equity 927,542     916,797  
   Total liabilities and shareholders’ equity $ 1,756,179     $ 1,765,819  
               
PLEXUS
NON-GAAP SUPPLEMENTAL INFORMATION TABLE 1
(in thousands, except per share data)
(unaudited)
           
  Three Months Ended
  Dec 31,   Oct 1,   Jan 2,
  2016   2016   2016
Operating profit, as reported $ 33,903     $ 23,651     $ 21,524  
Operating margin, as reported 5.3 %   3.6 %   3.5 %
                       
Non-GAAP adjustments:                      
Typhoon-related losses (1) —     2,871     —  
Accelerated stock-based compensation expense (2) —     5,210     —  
Restructuring and other charges* —     1,805     1,507  
Adjusted operating profit $ 33,903     $ 33,537     $ 23,031  
Adjusted operating margin 5.3 %   5.1 %   3.7 %
           
Net income $ 28,179     $ 19,093     $ 14,448  
           
Non-GAAP adjustments:          
Typhoon-related losses (1) —     2,871     —  
Related tax impact —     (718 )   —  
Accelerated stock-based compensation expense (2) —     5,210     —  
Restructuring and other charges* —     1,805     1,507  
Adjusted net income $ 28,179     $ 28,261     $ 15,955  
           
Diluted earnings per share $ 0.82     $ 0.56     $ 0.42  
           
Non-GAAP adjustments:          
Typhoon-related losses (1) —     0.08     —  
Related tax impact —     (0.02 )   —  
Accelerated stock-based compensation expense (2) —     0.15     —  
Restructuring and other charges* —     0.05     0.05  
Adjusted diluted earnings per share $ 0.82     $ 0.82     $ 0.47  
           
*Summary of restructuring and other charges          
Employee termination and severance costs $ —     $ 565     $ 1,394  
Other exit costs —     460     113  
Loss on sale leaseback of building —     780     —  
    Total restructuring and other charges $ —     $ 1,805     $ 1,507  
           
(1) During Q4F16 $2.9 million of charges were recorded in cost of sales; these charges resulted primarily from inventory losses sustained from a typhoon that impacted the Company's manufacturing facilities in Xiamen, China.
(2) During Q4F16 $5.2 million of accelerated stock-based compensation expense was recorded in selling and administrative expenses pursuant to the previously announced retirement agreement with the Company's former Chief Executive Officer.
PLEXUS
NON-GAAP SUPPLEMENTAL INFORMATION Table 2
  (in thousands)
(unaudited)
           
ROIC and Economic Return Calculations Three Months Ended   Twelve Months Ended   Three Months Ended
  Dec 31,   Oct 1   Jan 2,
  2016   2016   2016
Operating profit, as reported   $ 33,903         $ 99,439         $ 21,524  
Typhon-related losses + —     + 2,871     + —  
Accelerated stock-based compensation expense + —     + 5,210     + —  
Restructuring and other charges + —     + 7,034     + 1,507  
Adjusted operating profit   $ 33,903       $ 114,554       $ 23,031  
  x 4           x 4  
                 
                 
Annualized adjusted operating profit   $ 135,612       $ 114,554       $ 92,124  
Tax rate x 8 %   x 11 %   x 12 %
Tax impact   10,849       12,601       11,055  
Adjusted operating profit (tax effected)   $ 124,763       $ 101,953       $ 81,069  
                             
Average invested capital ÷ $ 720,197     ÷ $ 739,986     ÷ $ 753,078  
                             
ROIC   17.3 %     13.8 %     10.8 %
Weighted average cost of capital - 10.5 %   - 11.0 %   - 11.0 %
Economic return   6.8 %     2.8 %     -0.2 %
                       
  Three Months Ended
Average Invested Capital Dec 31,   Oct 1,   Jul 2,   Apr 2,   Jan 2,   Oct 3,
Calculations 2016     2016     2016     2016     2016     2015  
Equity $ 927,542       $ 916,797       $ 895,175       $ 871,111       $ 850,794       $ 842,272  
Plus:                      
Debt - current 78,879     78,507     78,279     2,300     2,864     3,513  
Debt - long-term 184,136     184,002     184,479     259,565     259,289     259,257  
Less:                      
Cash and cash equivalents (496,505 )   (432,964 )   (433,679 )   (409,796 )   (354,728 )   (357,106 )
  $ 694,052     $ 746,342     $ 724,254     $ 723,180     $ 758,219     $ 747,936  
                                               

 

Investor and Media Contact Susan Hanson +1.920.751.5491 susan.hanson@plexus.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PROYA Skincare Expands to Ulta: A Scientific Ambition

Updated Category News Views 89

A New Chapter for PROYA Bet you didn't see this one coming: a leading Chinese beauty brand, PROYA, is throwing its hat into the North American skincare ring, rolling out its science-backed skincare line nationwide at Ulta Beauty. The same brand that's been big news across Asia is now setting its sights on the U.S. with a stunning array of products that don't just promise...

Continue Reading
Genesys Works Nets Grant to Boost Youth Career Access

Updated Category News Views 106

A Windfall for Career Readiness Here’s a nugget of hope wrapped in a crisp announcement: Genesys Works, the not-for-profit that’s been busy nuancing the work-play balance for high school kids, is rolling with a $4 million boost from Ballmer Group. This move isn’t just pennies from heaven; it's a strategic play designed to gird young folks for the evolving demands of...

Continue Reading
Navigating Idaho's Massage Therapy School Pathways

Updated Category News Views 98

Cracking the Idaho Massage School Code Idaho folks diving into massage therapy education need a playbook—timing, training, and all the bumps along the way. This journey's not just book reading and back rubs; it’s a structured affair with rigid hours and some bureaucratic hurdling. Thank goodness for Kylee Evans, who’s spilling the beans on what goes down in Idaho...

Continue Reading
Lululemon Lawsuit Looms: Investors Face Key Decisions

Updated Category News Views 22

Seems Lululemon just tripped on its yoga mat. When a company like Lululemon Athletica, Inc (NASDAQ:LULU) sees a 17.38% slide in stock, every savvy investor knows there's more beneath the surface. Squarely in the crosshairs of a securities fraud class action, the brand synonymous with upscale athleisure faces harsh scrutiny. And the deadline's ticking—even the suits know...

Continue Reading
VinFast's Radical Mileage Warranty: Game-Changer?

Updated Category News Views 88

Revving Up: VinFast's Bold Battery Bet Some days it feels like every automaker is just looking for ways to tether drivers to mileage limitations, but VinFast is ripping up the rulebook. Their promise of a 10-year, unlimited-mileage battery warranty has got tongues wagging, and for good reason. Under typical policies, drivers with long commutes or adventurous spirits face...

Continue Reading
African Scholars Uncover Cangxi's Cultural Strategies

Updated Category News Views 28

Discovering Cangxi's Development Playbook Picture this: a band of African scholars deep-diving into China's rural heartland, Cangxi, in Sichuan province, trying to unlock the secrets behind its impressive cultural and industrial achievements. On November 4, a delegation from the Horn of Africa arrived as part of a training workshop organized by China's Ministry of Foreign...

Continue Reading
CytoSorbents Hits Financial Milestone in Q3 2026

Updated Category News Views 46

CytoSorbents' Financial Turnaround Imagine the smell of fresh opportunity wafting through CytoSorbents’ (NASDAQ:CTSO) corridors this quarter. The company just nudged into positive territory with its operating cash flow, which, let’s be honest, is like finding a nugget of gold amid last year’s rubble of losses. With $43,000 of positive operating cash flow in a world...

Continue Reading
HelloNation Elevates Contractors' Expertise at PHCC NC

Updated Category News Views 27

Times are changing, and the digital landscape keeps morphing—who can keep up? That's exactly what's on the agenda as McKenzie Finkhousen and Alton Baird lead HelloNation into the 2026 PHCC of NC Annual Meeting. This ain't just another LinkedIn meet-up—this is a proper gathering of minds in plumbing, heating, and cooling biz right at Harrah's Cherokee Casino Resort....

Continue Reading
DIR Launches WineWalrus: A New Era for Wine Lovers

Updated Category News Views 53

The Wine Industry's Digital Splash Ah, the wonderful world of wine—a place where culture, taste, and that sweet bouquet of a well-aged vintage collide. It’s no secret that the wine industry is a cash cow, raking in more than $323 billion annually in the U.S. alone. Digital Information Resources (DIR), a savvy player in tech and media circles, decided this bubbling...

Continue Reading
Tax Strategies for Small Businesses Before Year-End

Updated Category News Views 106

Understanding the Importance of Year-Round Tax Planning Every small business owner dreads the tax season—like a thunderstorm on a picnic day. But here's a nugget from Paul Kersten, an Accounting and Tax whiz in Shawano, Wisconsin: don't wait until April to sort your taxes. By then, it's all receipts and regrets. Instead, consider tax planning as a year-long vigil. Why?...

Continue Reading

Top 5 Most Recently Viewed Articles

Pagaya Technologies Secures $300 Million Auto Loan Funding

Updated Category News Views 175

Pagaya Technologies Strengthens Financial Position with Auto ABS Pagaya Technologies LTD. (NASDAQ: PGY), a leading global technology firm, has achieved an important milestone in its journey by successfully closing a substantial $300 million auto asset-backed securitization (ABS) transaction. This notable achievement, labeled RPM 2025-1, reflects Pagaya's innovative...

Continue Reading
Celebrating Excellence: Hilgers Graben Attorneys Shine in Legal Community

Updated Category News Views 296

Acknowledging Legal Excellence in Dallas Hilgers Graben’s Dallas office continues to make significant strides in the legal community, gaining noteworthy recognition. The managing partner, Grant Schmidt, along with senior counsel Andrew Bean, have both secured a spot on D Magazine’s distinguished list of the 'Best Lawyers Under 40.' This annual accolade celebrates...

Continue Reading
Tifiany Walker of Walker Healthforce: EY Entrepreneur Finalist 2025

Updated Category News Views 327

Earning Recognition in the Entrepreneurial Landscape Walker Healthforce, led by the inspiring Tifiany Walker, has made a significant mark in the entrepreneurial scene, recently being honored as a finalist for the Entrepreneur Of The Year 2025 Award. This initiative, celebrating its 40th year, has been the pinnacle of acknowledging business leaders who are not just...

Continue Reading
MerryLife Biomedical's TML-6 Shows Promise in Alzheimer's Trials

Updated Category News Views 142

Positive Phase 1 Results for TML-6 MerryLife Biomedical Inc., an innovative clinical-stage biotechnology company focused on neurodegenerative diseases, recently shared encouraging news about their investigational oral therapy, TML-6, targeting Alzheimer's disease. The recent Phase 1 trial indicated that TML-6 was well-tolerated and exhibited a favorable safety profile,...

Continue Reading
Clariant's Strong Q4 Results Signal Positive 2025 Outlook

Updated Category News Views 305

Impressive Quarterly Performance Clariant recently reported exceptional financial performance for the fourth quarter of 2024, showcasing growth across all its business segments. The company achieved sales of CHF 1.091 billion, reflecting a 5% increase in local currency compared to the previous year. This rise in sales can be attributed to a significant volume increase,...

Continue Reading